Sept. 10, 2025 — ZAP Surgical Systems, Inc. will make its debut at the 2025 ASTRO (American Society for Radiation Oncology) Annual Meeting, Sept. 28 – Oct. 1 in San Francisco, Calif. ZAP Surgical will showcase the ZAP-X Gyroscopic Radiosurgery platform alongside its internationally recognized, award-winning ZAP-Axon Radiosurgery Planning System*.

Sept. 11, 2025 — Naitive Technologies, a medical technology company developing AI-driven software to reimagine orthopedic care, has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its flagship product, OsteoSight. OsteoSight enables opportunistic assessment of bone mineral density (BMD) using standard X-rays acquired to investigate other clinical concerns, such as pain associated with arthritis or a fall.

Sept. 8, 2025 — Pathology plays a crucial role in the diagnosis of a variety of diseases, particularly cancer, through examination of patient tissue samples. With an estimated 70% of important medical decisions involving laboratory or pathology tests2, the availability of digitally stored pathology images is especially important as it has a significant impact on patient care.

Sept. 10, 2025 —GE HealthCare announced it has entered into an agreement to acquire icometrix, a company focused on providing AI-powered brain imaging analysis for neurological disorders such as Alzheimer’s disease to meet the growing demand for MRI in personalized treatment planning.

Sept. 9, 2025 — Radiation Detection Company (RDC), a provider of occupational radiation monitoring services, recently announced its NetDose Digital Dosimeter has been awarded the 2025 AHRA Innovation Award by the Association for Medical Imaging Management (AHRA) at its Annual Meeting in Las Vegas.

The AHRA Innovation Award recognizes excellence in medical imaging and healthcare administration, celebrating products and services that improve patient safety, clinical operations, and compliance.

Sept. 8, 2025 — A new clinical case study, presented by Qure.ai and Hacettepe University, Turkey, at the IASLC World Conference on Lung Cancer 2025 in Barcelona, shows that Artificial Intelligence (AI) can detect potentially malignant pulmonary nodules on routine chest X-rays (CXRs), even when the imaging was ordered for unrelated, non-respiratory conditions.

Sept. 3, 2025 — According to ARRS’ American Journal of Roentgenology (AJR), a commercial artificial intelligence (AI) system achieved high negative predictive value (NPV) but also demonstrated higher recall rates than radiologists when applied to large digital mammography (DM) and digital breast tomosynthesis (DBT) screening cohorts.

Sept. 4, 2025 — Sentec recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its LuMon Electrical Impedance Tomography (EIT) system for premature infant, infant, adolescent and adult patients — making it the first EIT technology in the United States available for premature infants and for spontaneously breathing patients. 

Sept. 4, 2025 — Ultrasound AI recently announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,369,883, "Artificial Intelligence System for Determining Clinical Values through Medical Imaging." The patent protects the company's proprietary system for determining current or future clinical or laboratory values directly from non-invasive medical images such as ultrasound.

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced that the first patient has been treated in its U.S. multi-center pancreatic cancer pilot study, known as IMPACT (Intratumoral Pancreatic Alpha Combination Trial), evaluating the safety, feasibility and efficacy of Alpha DaRT in combination with chemotherapy for patients with newly diagnosed unresectable locally advanced or metastatic pancreatic adenocarcinoma.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now